Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moutan Cortex for Chemotherapy-induced Peripheral Neuropathy
NCT07693374Withdrawn
- Sponsor
- Tainan Municipal An-Nan Hospital
- Start
- Aug 2022
- Primary completion
- Aug 2025
- Countries
- 1
01
Overview
Randomised trial of cortex moutan in chemotherapy-induced peripheral neuropathy (CIPN) (2 arms), sponsored by Tainan Municipal An-Nan Hospital. Primary endpoint: Brief Pain Inventory-Short Form at 4 weeks. Planned start Aug 2022; status: withdrawn.
02
Drugs
cortex moutan
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT07693374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07693374.